Nooruddin Shaik. 2023. “A Critical Review of Cinqair (Reslizumab) in the Treatment of Severe Asthma Patients”. Future Journal of Pharmaceuticals and Health Sciences 3 (2):126–133. https://doi.org/10.26452/fjphs.v3i2.442.